Evaluation of effect of specimen-handling parameters for plasma preparation tubes on viral load measurements obtained by using the Abbott RealTime HIV-1 load assay

Journal of Clinical Microbiology

Volumn 48, Issue 7, 2010, Pages 2464-2468

  Fernandes, Helen ^a   Morosyuk, Svetlana ^b   Abravaya, Klara ^c   Ramanathan, Madhuri ^a   Rainen, Lynne ^b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b BD Technologies   (United States)

^c Abbott Molecular Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASSAY; CENTRIFUGATION; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; NONHUMAN; PLASMA; PRIORITY JOURNAL; VIRUS LOAD; ADULT; ANALYSIS OF VARIANCE; BLOOD SAMPLING; DISEASE COURSE; EPIDEMIOLOGY; GENETICS; HIV INFECTIONS; PROCEDURES; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ADULT; ANALYSIS OF VARIANCE; BLOOD SPECIMEN COLLECTION; DISEASE PROGRESSION; EPIDEMIOLOGIC RESEARCH DESIGN; HIV INFECTIONS; HIV-1; HUMANS; LINEAR MODELS; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 77954454262     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00083-10     Document Type: Article

References (13)

1. Elbeik, T., P. Nassos, P. Kipnis, B. Haller, and V. L. Ng. 2005. Evaluation of the VACUTAINER PPT plasma preparation tube for use with the Bayer VERSANT assay for quantification of human immunodeficiency virus type 1 RNA. J. Clin. Microbiol. 43:3769-3771.
2. García-Bujalance, S., C. Ladron de Guevara, J. González-García, J. R. Arribas, F. Zamora, and A. Gutiérrez. 2007. Elevation of viral load by PCR and use of plasma preparation tubes for quantification of human immunodeficiency virus type 1. J. Microbiol. Methods 69:384-386. (Pubitemid 46551304)
3. Griffith, B. P., and R. M. Donald. 2006. Increased levels of HIV RNA detected in samples with viral loads close to the detection limit collected in plasma preparation tubes (PPT). J. Clin. Virol. 35:197-200.
4. Holodniy, M. 2006. HIV-1 viral load quantitation: a 17-year perspective. J. Infect. Dis. 194:S38-S44.
5. Holodniy, M., L. Rainen, S. Herman, and B. Yen-Lieberman. 2000. Stability of plasma human immunodeficiency virus load in VACUTAINER PPT plasma preparation tubes during overnight shipment. J. Clin. Microbiol. 38:323-326.
6. Kran, A.-M. B., T. O. Jonassen, M. Sannes, K. Jakobsen, A. Lind, A. Maeland, and M. Holberg-Petersen. 2009. Overestimation of human immunodeficiency virus type 1 load caused by the presence of cells in plasma from plasma preparation tubes. J. Clin. Microbiol. 47:2170-2174.
7. Lima, V., R. Harrigan, and J. S. G. Montaner. 2009. Increased reporting of detectable plasma HIV-1 RNA levels at the critical threshold of 50 copies per milliliter with the Taqman assay in comparison to the Amplicor assay. J. Acquir. Immune Defic. Syndr. 51:3-6.
8. Rebeiro, P. F., A. Kheshti, S. S. Bebawy, S. E. Stinnette, H. Erdem, Y. W. Tang, T. R. Sterling, S. P. Raffanti, and R. T. D'Aquila. 2008. Increased detectability of plasma HIV-1 RNA after introduction of a new assay and altered specimen-processing procedures. Clin. Infect. Dis. 47:1354-1357.
9. Sabino, E. C., N. J. Gaburo, J. P. Leite, M. Viecili, and L. G. Rosenfeld. 2004. Platelets may affect detection and quantitation of HIV RNA in plasma samples with low viral loads. J. Acquir. Immune Defic. Syndr. 37:1432-1433.
10. Salimnia, H., E. C. Moore, L. R. Crane, R. D. MacArthur, and M. R. Fairfax. 2005. Discordance between viral loads determined by Roche COBAS AMPLICOR human immunodeficiency virus type 1 monitor (version 1.5) standard and ultrasensitive assays caused by freezing patient plasma in centrifuged Becton-Dickinson Vacutainer brand plasma preparation tubes. J. Clin. Microbiol. 43:4635-4639.
11. Squires, K., A. Lazzarin, J. M. Gatell, W. G. Powderly, V. Pokrovskiy, J.-F. Delfraissy, J. Jemsek, A. Rivero, W. Rozenbaum, S. Schrader, M. Sension, A. Vibhagool, A. Thiry, and M. Giordano. 2004. Comparison of once-daily atazanavir with efavirenz, each in combination with fixed-dose zidovudine and lamivudine, as initial therapy for patients infected with HIV. J. Acquir. Immune Defic. Syndr. 36:1011-1019.
12. Stosor, V., F. J. Palella, Jr., B. Berzins, M. Till, A. Leake, J. S. Chmiel, and R. L. Murphy. 2005. Transient viremia in HIV-infected patients and use of plasma preparation tubes. Clin. Infect. Dis. 41:1671-1674.
13. Wan, H., A. Seth, L. Rainen, and H. Fernandes. 2010. Co-amplification of HIV proviral DNA and viral RNA in assays used for quantification of HIV-1 RNA. J. Clin. Microbiol. 48:2186-2190.